{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:50:37Z","timestamp":1790391037595,"version":"4.1.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,17]]},"abstract":"<jats:p>Alopecia areata (AA) imposes a complex multidimensional burden that extends far beyond visible hair loss, with psychosocial distress often shaped more by individual perceptions and stigma than disease severity. Treatment success should prioritize patient-reported outcomes, including psychological wellbeing and social functioning, rather than focusing solely on hair regrowth. While advances such as Janus kinase inhibitors have improved clinical and quality-of-life outcomes, significant inequities in access to both medical and supportive therapies persist, limiting optimal care. Additionally, the substantial and often overlooked financial burden of AA underscores the need for more equitable healthcare policies and cost-effective treatment strategies.<\/jats:p>","DOI":"10.1093\/ced\/llag177","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:32:28Z","timestamp":1776166348000},"page":"1732-1733","source":"Crossref","is-referenced-by-count":0,"title":["Alopecia areata: unseen burdens and unmet needs; comment on \u2018The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: evaluating patients\u2019 perspectives to guide therapy\u2019"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-8738","authenticated-orcid":false,"given":"Aparna","family":"Potluru","sequence":"first","affiliation":[{"name":"Department of Dermatology, Royal Hospital for Children, NHS Greater Glasgow and Clyde , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-7233","authenticated-orcid":false,"given":"Yasmin","family":"Nikookam","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St George\u2019s Hospital, St George\u2019s University Hospitals NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026081712361618200_llag177-B1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/ced\/llag112","article-title":"The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients\u2019 perspectives to guide therapy","volume":"51","author":"Darchini-Maragheh","year":"2026","journal-title":"Clin Exp Dermatol"},{"key":"2026081712361618200_llag177-B2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jpc.16678","article-title":"Psychosocial impact of alopecia areata in paediatric and adolescent populations: a systematic review","volume":"60","author":"Tan","year":"2024","journal-title":"J Paediatr Child Health"},{"key":"2026081712361618200_llag177-B3","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jocd.14416","article-title":"Alopecia areata: a psychodermatological perspective","volume":"21","author":"Torales","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026081712361618200_llag177-B4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bjd\/ljae385","article-title":"British Association of Dermatologists living guideline for managing people with alopecia areata 2024","volume":"192","author":"Harries","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026081712361618200_llag177-B5","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/ced\/llaf282","article-title":"Unequal NHS wig provision: toup\u00e9e or no toup\u00e9e, that is the question?","volume":"50","author":"De Brito","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026081712361618200_llag177-B6","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1002\/ski2.301","article-title":"Establishing the financial burden of alopecia areata and its predictors","volume":"4","author":"Zucchelli","year":"2024","journal-title":"Skin Health Dis"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag177\/68088972\/llag177.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/9\/1732\/68088972\/llag177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/9\/1732\/68088972\/llag177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:36:25Z","timestamp":1786984585000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/9\/1732\/8654697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":6,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llag177","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,4,16]]}}}